This inventor holds 1 USPTO granted patent and 1 EPO patent. Top assignee: Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.. Active years: 2022.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2022
Title: Hao Hu: Innovator in Pharmaceutical Compounds
Introduction
Hao Hu is a prominent inventor based in Chengdu, China. He has made significant contributions to the field of biopharmaceuticals, particularly in the development of innovative compounds for medical use. His work focuses on creating effective solutions for viral diseases.
Latest Patents
Hao Hu holds a patent for a solid form of dihydropyrimidine compound, along with its preparation method and applications. This patent, titled "Solid form of dihydropyrimidine compound and preparation method therefor and use thereof," discloses a solid form of (E)-3-((R)-4-(((R)-6-(2-chloro-4-fluorophenyl)-5-(methoxycarbonyl)-2-(thiazol-2-yl)-3,6-dihydropyrimidin-4-yl)methyl)morpholin-2-yl)acrylic acid. The patent also details a pharmaceutical composition that includes this compound and its use in preparing drugs aimed at preventing or treating viral diseases. Hao Hu has 1 patent to his name.
Career Highlights
Hao Hu is currently employed at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd. His role at the company allows him to engage in cutting-edge research and development in the biopharmaceutical sector. His expertise and innovative approach have positioned him as a valuable asset in the industry.
Collaborations
Hao Hu collaborates with several talented individuals in his field, including Jiaqiang Cai and Weibiao Han. These collaborations enhance the research and development efforts at Sichuan Kelun-Biotech Biopharmaceutical Co., Ltd.
Conclusion
Hao Hu is a dedicated inventor whose work in pharmaceutical compounds is making a significant impact in the fight against viral diseases. His innovative contributions and collaborations continue to advance the field of biopharmaceuticals.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile